Sutro Biopharma, Inc. Annual report pursuant to Section 13 and 15(d)

Stockholders' Equity (Tables)

12 Months Ended

Dec. 31, 2023

The Company has reserved common stock, on an if-converted basis, for issuance as follows:


	December 31,
	2023		2022
Common stock options issued and outstanding		7,905,032		7,310,611
Common stock awards issued and outstanding		5,244,873		3,958,478
Remaining shares reserved for issuance under 2018 Equity Incentive Plan and 2021 Equity Inducement Plan		1,777,919		1,541,706
Shares reserved for issuance under 2018 Employee Stock Purchase Plan		914,911		865,995
Warrants to purchase common stock		127,616		127,616
Total		15,970,351		13,804,406